斯科普斯
抗生素耐药性
全球卫生
行动计划
医学
抗性(生态学)
抗药性
政治学
梅德林
公共卫生
抗生素
生物
病理
法学
生态学
微生物学
作者
Youngmee Jee,Johan E. Carlson,Eric Rafai,Kunda Musonda,Tran Thi Giang Huong,Paula Daza,Wanchai Sattayawuthipong,Tae‐Ho Yoon
标识
DOI:10.1016/s1473-3099(18)30471-7
摘要
Antimicrobial resistance (AMR) presents a widespread, complex threat to global health and universal health coverage.1,2 Internationally, an estimated 700 000 deaths are attributed to AMR annually,3 with a projected economic impact of US$100 trillion by 2050.4 Worldwide, the burden of infectious diseases is increasing, particularly in low-income and middle-income countries (LMICs)5 and susceptible populations.6 The effectiveness of treatment for these infections, and the sustainability of health systems globally, are severely threatened by AMR.
科研通智能强力驱动
Strongly Powered by AbleSci AI